Summary: Hypoglycemia can cause brain dysfunction, brain injury, and death. The present study seeks to broaden current information regarding mechanisms of hypoglycemic brain in jury by investigating a novel etiology. The cat's high resistance to brain injury from hypoglycemia suggested that additional influences such as respiratory depression might play a facili tating role. Three groups of cats were exposed to fasting and insulin-induced hypoglycemia (HG; n = 6), euglycemic respi ratory depression (RD; n = 5), and combined hypoglycemic respiratory depression (HGIRD; n = 10). The HG animals were maintained at <1.5 mmol (mean I mmol) serum glucose concentration for 2 to 6.6 hours. The respiratory depression was associated with Pao2 and Paco2 values of -50 mm Hg for 1 hour and of -35 and -75 mm Hg, respectively, for the second hour. Magnetic resonance diffusion-weighted imaging esti mated brain energy state before, during, and after hypoglyce mia. The hypoglycemic respiratory depression exposures were terminated either to euglycemia (n = 4) or to hyperglycemia (n = 6). Brain injury was assessed after 5 to 7 days of survival. Cats exposed to hypoglycemia alone maintained unchanged diffusion coefficients; that is, they lacked evidence of brain energy failure and all six remained brain-intact. Only I of 5
euglycemic RD but 10 of 10 HGIRD cats developed brain damage (HG and RD vs. HGIRD, P < 0.01). This difference in brain injury rates suggests injury potentiation by hypoglycemia and respiratory depression acting together. Three injury pat terns emerged, including activation of microglia, selective neu ronal necrosis, and laminar cortical necrosis. Widespread acti vation of microglia suggesting damage to neuronal cell pro cesses affected all damaged brains. Selective neuronal necrosis affecting the cerebral cortex, hippocampus, and basal ganglia was observed in all but one case. Instances of laminar cortical necrosis were limited to cats exposed to hypoglycemic respi ratory depression treated with hyperglycemia. Thus, treatment with hyperglycemia compared with euglycemia after hypogly cemic respiratory depression exposures significantly increased the brain injury scores (24 ± 6 vs. 13 ± 2 points; P < 0.05). This new experimental hypoglycemia model's contribution lies in recognizing additional factors that critically define the occur rence of hypoglycemic brain injury. Key Words: Hypoglyce mic encephalopathy-Hypoxia/hypercarbia-Insulinlfasting Diffusion-weighted magnetic resonance imaging-Hyper glycemic treatment.
lates (Surtees and Leonard, 1989; Selzer, 1989) . Hypo glycemia is the most frequent acute complication of in sulin-dependent diabetes mellitus, causing symptoms ranging from autonomic responses to seizures and coma (Soltesz, 1993; Davis et aI., 1997) . Cognitive tasks are performed variably in the presence of hypoglycemia, but performance of more complex tasks deteriorates when glycemia declines to -3 mmol (Heller and MacDonald, 1996) . Fasting commonly precipitates hypoglycemic coma in the presence of drug toxicity and in diabetics treated with insulin (Selzer, 1989; Davis et aI., 1997) .
Fortunately, brain injury from hypoglycemia occurs relatively infrequently in humans. Thus, among 1,307 patients experiencing drug-induced hypoglycemic coma, whereas 8% died, only 2% developed neurological se quelae (Selzer, 1989) . The literature references only iso lated cases of hypoglycemic encephalopathy, but large series are absent (Kalimo and Olsson, 1980; Auer et aI., 1989) , suggesting an infrequent occurrence of hypogly cemic brain damage. Even so, exposure to hypoglycemia should be avoided for several reasons. Infants experienc ing hypoglycemia have an increased rate of impaired neurological development (Lucas et aI., 1988; Rovet et aI., 1987; Bergada et al., 1989) . Young diabetic patients suffer a high death rate of 1/800/year due to hypoglyce mic episodes (Borch-Johnson and Helweg-Larsen, 1993) . Furthermore, the incidences of cerebral cortical atrophy and of cognitive declines are higher in type 1 diabetic patients who experience severe hypoglycemic episodes (Wredling et aI., 1990; Deary et aI., 1993; Per ros et aI., 1997) . The finding that closely controlling the blood glucose levels in type 1 diabetic patients reduces microvascular complications (DCCT Research Group, 1993) , though at the price of increasing the occurrence of severe hypoglycemic episodes (Deary et aI., 1993; Lin coln et aI., 1996) , implies a difficult risk assessment that is predicated on knowledge of hypoglycemic brain injury mechanisms.
Siesjo, Auer, and colleagues have contributed impor tantly to the understanding of the brain physiology and pathology of hypoglycemia using a rat model (Auer and Siesjo, 1993) . Rats exposed to severe hypoglycemia without respiratory or circulatory disturbances showed marked reductions of brain energy state and damage to brain that correlates with the duration of exposure. These experiments demonstrate that hypoglycemia on its own can damage the brain. Though valuable, the relevance of this rat model of hypoglycemia to human hypoglycemic brain injury has limitations. For example, in infants, damage to the brain occurs at moderate levels of hypo glycemia that are higher than those required experimen tally (Lucas et aI., 1988) . Contrarily, the human brain often seems remarkably resistant to hypoglycemic injury and damage develops unpredictably, though with an es pecially high prevalence in infants and young children (Rovet et aI., 1987; Bergada et aI., 1989; Lucas et aI., 1988) . Also, seizures are closely associated with human hypoglycemia (Davis et aI., 1997) , although they are ab sent in the rat model of hypoglycemia. The present model seeks to broaden current understanding of hypo glycemic brain injury mechanisms and to afford expla nations for clinical facts evading explanation by previous models.
To test our finding that respiratory depression during exposure to hypoglycemia enhances brain injury, we ex posed three groups of cats to marked hypoglycemia with maintained cardiorespiratory functions (HG group), to respiratory depression in the presence of normal serum glucose concentration (RD group), and to respiratory depression in the presence of hypoglycemia (HG/RD group). Further, as our earlier findings suggest that after exposure to marked hypoglycemia brain injury may be influenced by the level of glycemia achieved during the restoration of blood glucose levels (de Courten-Myers et aI., 1992), we tested whether treatment to hyperglycemic overshoots affects brain injury.
METHODS

Animal groups
Animal care and handling followed the guidelines of the National Institutes of Health publication no. 85-23 (rev. 1985) . The institutional animal care and use committee had approved the research protocols. We exposed three groups of conditioned adult cats of either sex (>2 kg of body weight) to marked hypoglycemia, during which the vital signs were maintained normal and stable (HG group); to euglycemic respiratory de pression (RD group); and to hypoglycemic respiratory depres sion (HG/RD group). Glycemia levels of <1.5 mmol were de fined as marked hypoglycemia. The HG group consisted of six cats exposed to escalating durations of marked hypoglycemia with their cardiovascular and respiratory status remaining in the normal range. The RD group encompassed five cats exposed to 2 hours of euglycemic respiratory depression (asphyxia); the severity of the respiratory depression was moderate during the first hour and marked during the second hour when it regularly induced arterial hypotension. The third group (HG/RD), com prising 10 cats, was exposed to 3 hours of hypoglycemia; dur ing the first hour, normal cardiorespiratory functions were maintained, whereas during the subsequent 2 hours, the same respiratory depression exposure was induced as in the RD group. The cats of this latter HG/RD group were randomly assigned to two treatment groups: four cats in which the HG/ RD exposure was terminated to euglycemic levels and six cats in which the exposure was terminated to markedly hypergly cemic levels.
All cats received intensive postprocedural care so that their brains could be examined after 5 to 7 days, permitting brain pathological damage to develop and be unequivocally present on histology.
Anesthesia and surgical preparation
Pentobarbital (Nembutal) anesthesia permitted the prolonged anesthesia required for up to 12 hours of animal experimental exposure and postprocedural treatment. Anesthesia was in duced with pentobarbital (35 mglkg of body weight) injected intraperitoneally. Anesthesia was maintained thereafter with 2 mglkg/h additional intravenous injections, until discontinued after exposure to hypoglycemia and/or respiratory depression and the blood respiratory gases and serum glucose concentra tion returned to a normal range and the intravascular monitor ing catheters were removed. This is the same anesthetic regi men we have used in other experimental studies requiring ex tended periods of anesthesia (de Courten-Myers et a!., 1994) . Clinically, barbiturates are widely used to manage elevated intracranial pressures that prove refractory to conventional methods of treatment, and they often are used over prolonged periods (Woster and LeBlanc, 1990) . A thermistor probe, in serted in the rectum, served to continuously record core body temperature.
After the animal achieved a surgical level of anesthesia, we inserted polyethylene catheters aseptically into blood vessels for monitoring. Femoral artery and vein catheters were intro-duced through an inguinal cutdown. The catheter tips were threaded forward to reach the thoracic aorta and inferior vena cava. The intraarterial catheter pennitted withdrawal of blood samples and recording of pulsatile or mean arterial blood pres sure. Heart rate was derived from the pulsatile pressure wave fonn, and all cardiovascular parameters were continuously re corded. The intravenous catheter permitted infusion of anes thesia, insulin, paralyzing agent, and saline and glucose solutions. The animals were ventilated with a pediatric respi rator following a tracheotomy and insertion of a cuffed endo tracheal tube. The electroencephalogram (EEG) was recorded in seven animals that were not studied with magnetic resonance imaging (MRI) techniques (three subjected to hypoglycemia alone and four to combined hypoglycemic respiratory depres sion). Subcutaneous electrodes placed symmetrically over the frontoparietal cortex and a nasal reference electrode served for the continuous EEG recordings.
Fasting and hypoglycemia
Regular insulin (3 U/kg intravenously) was injected to in duce marked hypoglycemia in the cats that had been food de prived for 48 hours before study. The animals also had received a priming dose of 1.5 Ulkg intramuscularly 12 hours before study. Marked hypoglycemia «1.5 mmol serum glucose con centration; normal = 5 to 6 mmol) developed within -I hour after the insulin injection, and hypoglycemic levels were main tained with additional 0. 3 U/kg intravenous doses. The duration of hypoglycemia was varied from 2 to 6.6 hours among the HG group and was fixed at 3 hours for the HGIRD group exposed to combined hypoglycemia and respiratory depression. Serum glucose concentrations were determined enzymatically using a Beckman Glucose Analyzer II with calibrations before each measurement.
The animals of the RD and HGIRD groups also were food deprived for 48 hours before exposure to render them compa rable with the animals of the HG group and to limit the hyper glycemic response to the stress of RD. Exposure to respiratory depression markedly increases the cats' glycemia levels (up to 50 mmol) when they have been normally fed (de Courten Myers et aI., 1985) . Thus, all three animal groups (HG, RD, and HGIRD groups) were similarly fasted prior to study.
Physiologic monitoring
The arterial blood pressure, heart rate, and core temperature of all animals were continuously monitored on a multichannel polygraph before, during, and after according to the conditions of the experiment. The EEG was monitored only in those ani mals that did not undergo MR studies. Arterial blood respira tory gases, pH, and serum glucose concentrations were mea sured at 30-minute intervals or as needed. Core temperature was maintained in the normal range for cats (38.5 ± 0.5°C) using a thermostatically controlled water blanket.
Respirator
During hypoglycemia, respiratory depression, hypoglycemic respiratory depression, and recovery, all cats were mechani cally ventilated to maintain their blood gases within physi ologic limits or the experimentally prescribed limits by adjust ing the respirator settings. The respiratory gas values of respi ratory depression, simulating those that may occur during marked hypoglycemia, were induced for 2 hours in the cats of the RD and HG/RD groups by reducing the respirator rate and ventilation volume. For the first hour, we induced a moderate degree of asphyxia (Paco2 and Pao2 -50 mm Hg). Thereafter, the respirator settings were further changed so as to lead to a more marked asphyxia ( Hg) for the second and final hour. Exposure to the marked asphyxia depressed the animal's cardiovascular perfonnance, causing several (usually three) hypotensive episodes with mean arterial blood pressure reductions below 60 mm Hg. The car diovascular perfonnances of all animals were closely moni tored, and episodes of hypotension were terminated within 1 to 2 minutes by temporarily increasing the ventilator rate and stroke volume.
Magnetic resonance imaging
To determine the onset of brain energy failure, sequential diffusion-weighted imaging (DWI) was carried out at 30-minute intervals from three regions of interest in six studies (three each in the HG and the HGIRD groups). Diffusion weighted imaging is recognized as a sensitive method of as sessing energy failure by measuring the apparent diffusion co efficient (ADC) of water, which depends principally on the extent of "free," that is, extracellular water (Busza et aI., 1992; Hossmann et aI., 1994) . During brain energy failure, the ces sation of ionic pumping causes "free" water to move from the extra-to the intracellular compartments, where it is bound prin cipally to proteins accompanied by a marked decline in the brain ADC.
Because of the sensitivity of the DWI to motion artifact, all animals' heads were positioned securely within the head coil and magnet with the aid of a custom-designed cat headholder. The anesthetized and ventilated animals also were paralyzed with vercuronium bromide (Norcuron; 0.10 mg/kg intrave nously) initially supplemented by 0.01 mg/kg intravenously every 30 minutes for the duration of the MR studies.
The DWI measurements were performed on a 3.0 T Bruker Biospec 30/60 MR scanner (Bruker Instruments, Karlsruhe, Germany) equipped with an actively shielded 30-cm gradient. A custom-designed 16-column birdcage radiofrequency coil was built to accommodate the animal's head and timed to the 125-MHz MR frequency. The regions of interest were pro jected on coronal slices of T2-weighted images: The midtha lamic slice served for the placement of two superolateral re gions of interest containing cerebral cortex, white matter, and hippocampus, and a centrally located region of interest was positioned over the thalamus/upper brains tern, Four spin echo diffusion-weighted scans were acquired with different diffusion b values to a maximum b of 9,390.5 s/cm 2 , a relaxation time of 2,000 ms, and a slice thickness of 3 mm. The ADCs were calculated by exponential line fit to each im age pixel as a function of the b value. Alterations within each region of interest are reported as percentage changes relative to a standard containing gadolinium-doped water placed in the cat's ear (Kimmich and Hoepfel, 1987) .
Treatment to ell-and hyperglycemia
The hypoglycemia of the HG group cats was terminated by infusion of 3.3 mL/kg glucose solutions over 10 minutes. The HG group received infusions of 10% dextrose in water. The animals of the HGIRD group were divided randomly into two subgroups. The six cats treated to hyperglycemia received 30% dextrose in water, and the four cats treated to euglycemia (or to minimal degrees of hyperglycemia) received a solution con taining 1 part 50% dextrose in water and 4 parts 25% mannitol. The addition of mannitol to the infusate of the latter group ensured the two groups were infused with solutions of the same osmolality in spite of a threefold difference in glucose content. The levels of glycemia achieved were maintained for 2 hours with additional rate-adjusted infusions of 10% glucose solu tions. All animals also received 30 mL/kg isotonic saline throughout the day of exposure.
Postoperative care
All animals were intensively monitored for at least 2 hours after termination of the experimental conditions. After they resumed adequate spontaneous breathing and were in stable cardiovascular conditions, monitoring catheters were removed except for the venous line and incisions were sutured. When they had awakened from anesthesia, they were transferred to a temperature-controlled intensive care unit until they recovered fully. Glycemia continued to be monitored until stable normo glycemia was restored, and the venous catheter was usually removed the next morning. Fluid (30 to 40 mL/kg/day) was administered first intravenously and then subcutaneously or per os until the animals resumed feeding on their own and could stand and walk. Hand feeding was started on the first postop erative day and continued as long as necessary. Nalbuphine hydrochloride (Nubain; I mg/kg) was administered three times per day for 3 days to control pain postoperatively. All animals were allowed to survive for 5 to 7 days (except for a single cat that died on the third postoperative day) to permit definitive pathologic changes to take place in the brain. All animals that died during exposure or within the first 2 days following ex posure (one in the HG, one in the RD, and six in the HG/RD groups) were excluded from this study. All animals used in the study were killed under deep pentobarbital anesthesia (60 mg/ kg intraperitoneally), and their brains were fixed by in situ vascular perfusion using 10% buffered formalin. The brains, after removal, were postfixed for 2 weeks in 10% formalin.
Brain pathologic examination
The formalin-fixed brains were examined for focal lesions and for evidence of brain edema. The entire brain was sliced into six standard coronal sections: level I through the anterior frontal lobes, level II through the anterior basal ganglial posterior frontal lobes, level III through the midthalamus/ anterior hippocampus, level IV through the posterior hippo campus/parietal lobe, level V through the upper brainsternl cerebellum, and level VI through the lower brains tem/ cerebellum. The brain slices then were embedded in paraffin for preparation of whole-mount hematoxylin and eosin-stained histologic slides. Select areas were studied using immunohis- tochemical techniques to demonstrate glial fibrillary acidic pro tein, a marker for reactive astrocytic gliosis.
The types and extent of brain damage were assessed semi quantitatively with the examiner blinded as to the individual animal's exposure type. The three types of brain injury ob served included laminar cortical necrosis, selective neuronal necrosis, and activation of microglia, as illustrated in Fig. 1 . In addition to recording the mere presence or absence of brain damage, we used a simple scoring system to semiquantitatively assess the extent of brain injury. The score was composed of the sum of points assigned for each of the three injury types and level with the right and left cerebral hemisphere scored sepa rately on levels II, III, and IV. One point was assigned each for the presence of activation of microglia and for selective neu ronal necrosis. Two points were assigned to the occurrence of laminar cortical necrosis, as this change represents a more marked type of injury, as can be seen in Fig. 1 .
Thus, the seven histologic sections from the cerebral hemi spheres yielded each 0 to 4 points, and as laminar cortical necrosis does not occur in the brainsternlcerebellum, the re maining two sections yielded each 0 to 2 points. This pathology score ranged from a minimum of 0, indicating no damage, to a maximum of 32 damage points.
Statistical analyses
Monitored physiologic parameters and pathology scores were expressed as means ± SD for each group, and group differences were assessed with the two-tailed Student t test. The brain injury rates in the different groups were compared using Fischer's exact test, and Wilcoxon's range test verified the treatment groups' differences in extent of brain injury. A level of P < 0.05 was accepted as statistically significant.
RESULTS
Physiologic changes
The cats composing the HG/RD group compared with the HG and RD groups, respectively, exhibited closely similar magnitude and duration of hypoglycemia or of respiratory depression's changes in respiratory gas com position of arterial blood. The two treatment HG/RD subgroups of cats were closely comparable during expo sure but differed by design in the glycemia levels main tained during the treatment phase. Tables 1 and 2 present the various experimental groups' values for critical vari ables displayed during specific phases of the study. Fig  ure 2 shows the average glycemia values experienced over time by the different experimental groups. Thus, the animals of corresponding experimental groups were ex posed to similar durations of hypoglycemia and/or respi ratory depression and showed similar experimental val ues of serum glucose concentration or blood respiratory gas composition and mean arterial blood pressure during the critical phases of the study, with one exception. Due to escalation of the duration of hypoglycemia in the HG group from 2 to 6.6 hours but a fixed 3-hour duration in the HGIRD group, the HG group experienced a signifi cantly longer exposure to <l .5 mmol serum glucose con centrations than did the HG/RD group. Guided by the rat hypoglycemia studies (Auer and Siesjo, 1993) , we started with 2-hour HG exposures, as they yielded at tenuated EEGs for cumulatively >30 minutes. Because brain injury did not ensue, we prolonged the exposure progressively up to more than threefold, but even so, all six animals of the HG group remained brain-intact. De spite the nearly twofold shorter mean duration of expo sure, it was the HG/RD group that later demonstrated brain injury (see below).
We deprived all cats of food for 2 days before their experimental exposure to facilitate the induction of marked hypoglycemia (Myers and Kahn, 197 1) and to limit the hyperglycemic responses to asphyxia imposed during exposure to respiratory depression (de Courten Myers et aI., 1985) . In normally fed cats, asphyxia induced hyperglycemia may reach levels as high as 50 mmol (de Courten-Myers et aI., 1985) . Thus, the fasted cats exposed to respiratory depression alone developed serum glucose concentrations that averaged only 10. 1 ± 3.1 mmo!, indicating that this group's hyperglycemic re sponse was significantly attenuated. Even so, they did not remain strictly euglycemic but became slightly hy perglycemic during asphyxia (Fig. 2) . However, in spite of the fact that higher glycemia levels increase brain injury due to asphyxia (de Courten- Myers et aI., 1985) , four of five animals of this group remained brain-intact.
Among the animals exposed to hypoglycemic respira tory depression, the stress from asphyxia and hypoten sion elevated transitorily the serum glucose concentra tions, necessitating the administration of additional insu lin. Despite the additional insulin, the cats exposed to hypoglycemic respiratory depression exhibited signifi cantly higher serum glucose concentrations during the exposure than did the cats exposed to hypoglycemia alone (2.3 ± 1.6 vs. 1.0 ± 0.3 mmol; P < 0.05, respec tively). Therefore, the brain injury in all 10 HGIRD ani mals occurred in a setting of moderate hypoglycemia, whereas the intact brains of the cats exposed to hypo glycemia alone were seen despite their more marked and prolonged hypoglycemia (Fig. 2) . The cats exposed to hypoglycemic respiratory depression and subsequently treated to eu-or hyperglycemia showed similar levels of serum glucose concentrations during hypoglycemic re spiratory depression exposure (2.0 ± l.6 vs. 2.5 ± l.9 mmol, respectively). Treating the hypoglycemia of the cats of these two treatment subgroups with infusates dif fering in glucose content but similar osmolality produced significantly different glycemia levels of 22.7 ± l.8 and 8.7 ± 0.8 mmol in the hyper-and euglycemic groups, respectively (Fig. 2) .
The animals regularly developed seizure activity dur ing exposure to marked hypoglycemia whether or not they were additionally exposed to respiratory depression. In contrast, the animals exposed to respiratory depression alone, without hypoglycemia, failed to show seizures. Seizures, usually recurrent, were identified in nonpara Iyzed animals by episodes of tonic-clonic movements accompanied by spike and wave activity in their EEG and transient increases in mean arterial blood pressure. The occurrence of the seizures regularly prevented sus tained periods of isoelectric EEG, as whenever a cat's EEG attenuated, it would develop seizures that in tum would cause a transitory increase in the serum glucose concentration and a resumption of cerebral electrical ac tivity.
The occurrence of seizures failed to correlate with development of brain injury because >80% of cats de veloped hypoglycemic seizures when exposed either to hypoglycemia alone (remaining brain intact) or to hypo glycemic respiratory depression causing brain damage. Whether the extent of brain injury correlates with seizure frequency could not be determined from the present study because the number of animals with EEG record ings was too small in the two treatment HG/RD sub groups. The EEGs were not recorded in animals under going MR studies because EEG electrodes, even when nonferrous, interfere with the homogeneity of the mag netic fields. 
Diffusion-weighted magnetic resonance imaging
Three of the six cats exposed to hypoglycemia, all of which maintained a normal cardiovascular performance and a normal range of respiratory gas values, were fol lowed with sequential DWI studies. In all three, the ADCs remained stable throughout the period of obser vation, which included the control period and the period of exposure to prolonged marked hypoglycemia, as is illustrated in Fig. 3 . Three cats studied in the HG/RD group during the control period and during hypoglyce mia showed stable ADCs. When the asphyxial state was added, the brain ADCs invariably increased (Fig. 3 ).
Brain pathology
The brain pathologic findings of the cats exposed to hypoglycemia, respiratory depression, and hypoglycemic respiratory depression with their subgroups treated to eu and hyperglycemia, respectively, are summarized and il lustrated in Tables 1 and 2 Brain pathology scores of cats exposed to hypoglycemia alone (HG group), to euglycemic respiratory depression (RD group), and to combined HG/RD (with their two treatment sub groups). All cats exposed to prolonged hypoglycemia where the cardiorespiratory functions were maintained unchanged (HG group) remained brain-intact. Exposure of cats to euglycemic re spiratory depression caused only one in five cats to develop brain injury. In contrast to the low brain injury rates among the HG and RD groups, cats exposed to combined hypoglycemia plus respi ratory depression (HG/RD) all showed brain damage (10/10). Of the cats in the HG/RD group, those treated to euglycemia showed significantly less extensive brain damage than did their peers treated to marked hyperglycemic overshoots.
cular and respiratory functions maintained essentially unchanged despite hypoglycemic exposure periods last ing as long as 6.6 hours showed no pathologic changes on brain examination (all six showed a brain pathology score of 0). Only one of the five cats exposed to respi ratory depression alone showed damage to its brain (with a pathology score of 20 points). The remaining four cats remained brain-intact, leading to a mean ± SD pathology score of 4 ± 9 for the RD group as a whole. In contrast, all 10 cats exposed to hypoglycemic respiratory depres sion (3 hours of marked hypoglycemia, the last 2 hours also with respiratory depression) developed significant brain damage (P < 0.005, rate of injury in HG/RD vs. HG and RD groups). The pathology scores of the 10 HG/RD cats ranged from 11 to 30 points (group mean ± SD = 20 ± 7). Figure 4 depicts the individual pathology scores from the animals of the three groups: The HG and the RD groups differ significantly from the HG/RD group but not from each other. The present hypoglycemic brain injury model in cats reproduces well the brain anomalies of human hypogly cemic encephalopathy with neuronal damage to cerebral cortex, hippocampus, and basal ganglia (Kalimo and Olsson, 1980; Auer et al., 1989) . We observed three patterns of injury: widespread activation of microglia, a characteristic feature of hypoglycemic injury (Myers and Kahn, 1971) ; selective neuronal necrosis of the cerebral cortex, hippocampus, and basal ganglia (especially cau date nucleus); and laminar cerebral cortical necrosis. These three patterns of brain injury are illustrated in Microglial activation was observed in all 10 HG/RD brains, representing the only type of injury in I cat. Ac tivation of microglia was observed in brain regions that also showed loss of neurons, namely, cerebral cortex, hippocampus, and basal ganglia. The process, though, extended far beyond these regions to also affect the thalamus and brainstem nuclei lacking neuronal soma injury. Activated microglial cells frequently were ori ented along neurites, suggesting they were appearing in response to damage to neuronal processes. The cerebel lum was consistently spared from recognizable damage.
Selective neuronal necrosis was observed in 9 of the 10 damaged HG/RD brains, whereas laminar cortical ne crosis was segregated to 5 of the 6 cats in the subgroup treated to hyperglycemia (and was also present in the 1 brain-damaged euglycemic RD exposure cat). Thus, the cats exposed to hypoglycemic respiratory depression and treated to euglycemia failed to develop laminar cortical necrosis, accounting for much of the difference in pa thology scores observed between the two treatment groups (shown below). Selective neuronal and laminar cortical necrosis elicited reactive astrocytic gliosis and isolated microglial activation did not, as was demon strated by immunoreactivity for glial fibrillary acidic protein in the affected regions. Laminar cortical necrosis affected preferentially the superolateral convexity cere bral cortex, whereas selective neuronal necrosis was found also medially along the sagittal fissure, the CAl segment of the hippocampus, the subiculum, and the cau date nucleus. Though overall there were strong similari ties, minor differences emerged in the distribution pat tern of hypoglycemic brain injury in rats (Auer et al., 1984) compared with the present study in cats. The strong preference to damage layer II neurons seen after hypoglycemic exposures in rats was less striking in this study, there was no involvement of the dentate gyrus of the hippocampus, and the preferential damage to regions of the caudate nucleus near the ventricle was not appar ent.
Treating the cats exposed to hyperglycemic respirato ry depression to hyper-and euglycemia, using osmoti cally balanced solutions, led to significantly higher treat ment glycemia levels in the six hyper-than in the four euglycemia animals: 22.5 ± 1.7 vs. 8.7 ± 0.8 mmol; P < 0.01. The cats exposed to hyperglycemic respiratory de pression and treated to hyper-or euglycemia also dif fered significantly in their pathology scores: 24 ± 6 vs. 13 ± 2 points; P < 0.005, Student's t-test; P < 0.05, Wilcoxon's rank test.
DISCUSSION
The present study demonstrates five main findings: (1) Cats exposed to marked and prolonged hypoglycemia with preserved cardiorespiratory functions remained brain-intact. (2) Eighty percent of cats exposed to eugly cemic respiratory depression remained brain-intact. (3) In contrast, combined exposure to hypoglycemia and re spiratory depression (elevated Paco2 and decreased P02 values) caused brain damage in all 10 cats, even though the severity of the hypoglycemia was less than in the HG group. (4) Cats exposed to hypoglycemia and to hypo glycemic respiratory depression showed no evidence of brain energy failure. (5) Cats exposed to combined hy poglycemic respiratory depression treated to hyper compared with euglycemia showed substantially greater brain injury.
Cats exposed to marked hypoglycemia alone with maintained cardiorespiratory status showed stable brain ADCs. This stability of the brain ADC suggests the brain maintained its energy state despite a severe and pro longed hypoglycemia. All of these cats also failed to show brain damage. Thus, cat exposure to marked hy poglycemia for prolonged periods is not necessarily as sociated either with brain energy failure or with brain damage, provided the animals do not experience a sig nificant respiratory depression. This result contrasts with the ADC findings of Hasegawa et al. (1996) , using a rat hypoglycemic model. Auer et al. (1984) and Auer and Siesjo (1993) have identified cerebral energy failure to accompany a flat EEG and reliable brain injury in the same rat hypoglycemia model even though cardiorespi ratory functions are fully maintained.
This difference in the brain pathologic consequences of insulin-induced hypoglycemia of comparable severity in the cat and rat is perplexing. Given the difference in brain energy state in the two models, reasons may in clude differences in body/brain size ratios that may im ply greater stores of alternative energy sources available during hypoglycemia in larger mammals; also, the greater metabolic rate of rats than cats may lead more readily to a depletion of brain energy in the rat. A com pelling reason for the two model's opposite brain patho logic outcomes may be the protective effects of pro longed fasting before the study, which provided ketone bodies serving as an alternative fuel for the hypoglyce mic cat brain (Senior and Sadeghi-Nejad, 1989) . During prolonged fasting, as was used in the present study to facilitate the induction of insulin hypoglycemia, free fatty acids replace glucose as the main fuel of the body while the brain remains the major consumer of glucose. However, the brain energy needs then are supplemented by ketones, a glucose-sparing fuel (Senior and Sadeghi Nejad, 1989) . Thus, it appears likely the brain energy state may have been preserved and brain damage averted during the prolonged severe hypoglycemia through the availability of ketones. A similar protection may take place in humans suffering marked hypoglycemia as fast ing is a frequent predisposing factor for development of hypoglycemic reactions in type 1 diabetes (Mortensen and Hougaard, 1997) and in drug-induced hypoglycemia (Seltzer, 1989) . Lewis et al. (1974) showed that glucose concentrations in blood, cerebrospinal fluid, and brain tissue correlate tightly until below 3 mmol blood glucose levels when calculated intracellular glucose concentrations become depleted, accompanied by reductions in glycogen, glu cose-6-phosphate, lactate, and citric cycle intermediates followed by declines in alanine, [3-aminobutyric acid, glutamine, and glutamate. Similarly, Silver and Erecin ska (1994) demonstrated that brain extracellular glucose concentrations parallel those of serum during hypo-and hyperglycemia and are similar to whole-brain glucose concentrations. This suggests that no major gradients for glucose exist across brain cell membranes. During hy poglycemia, the brain glucose content declines, reflect ing the high Km of the two main glucose transporters (GLUT-l at the blood-brain barrier and GLUT-3 at the cell membrane) (Lund-Andersen, 1979; Gould et aI., 1991) . Because the velocity of glucose influx into brain exceeds that of its phosphorylation, intracellular glucose concentrations remain constant until the serum glucose concentration declines below 2.5 mmol (Pellegrino et aI., 1990) . At that point, compensatory physiologic mecha nisms operate to increase cerebral blood flow and en hance glucose transport (Abdul-Rahman et aI., 1980; Cil luffo et aI., 1982) . Because pentobarbital inhibits the ac tivity of the GLUT -1 carrier in cultured cerebral capillaries (Honkanen et aI., 1995) , the present study's use of pentobarbital anesthesia would have predicted a greater, not a lesser, vulnerability to hypoglycemia. The brain-protective properties of barbiturates, mediated in part through reduced metabolic rates, seem not to have contributed substantially to the HG cat exposure's failure to cause brain injury because the same anesthetic regi men applied equally to the brain-injured HG/RD ani mals.
In the present study, the addition of respiratory depres sion during hypoglycemia greatly increased the brain in jury rate from 0% in HG exposures and 20% in eugly cemic RD exposures to a full 100%. This large increase suggests potentiation of brain damage from the com bined exposure. Though the mechanisms responsible for this effect are not fully elucidated, the following studies relate to this finding.
Hypoxia induced by respiring animals with 3% O2 decreases brain extracellular glucose concentration by -80% despite increases in blood glucose concentration indicating an increased brain glucose utilization and/or decreased glucose transport (Lund-Anderson, 1979) . Thus, superimposing a respiratory depression on a marked hypoglycemia may further reduce the availabil ity of brain tissue glucose. Nonetheless, brain energy failure seems still not to have ensued as the brain ADCs increased rather than decreased, the change associated
with energy failure (Hossmann et aI., 1994; Hasegawa et aI., 1996) . Though preliminary, repeated assessment of brain energy state with 31p MR spectroscopy during HOI RD exposures confirmed the preservation of brain ATP levels (unpublished data) that contrasts with similar stud ies of hypoglycemic rat brains with isoelectric EEGs showing loss of high-energy phosphates (Behar et aI., 1985) . Even so, because the DWI and MR spectroscopy methods average relatively large brain regions, it is pos sible that focal brain regions' energy failure or milder degrees may not have been detectable.
Of interest are also in vitro studies of combined hyp oxia and hypoglycemia that provoke far greater increases in intracellular Ca 2 + than does exposure to either condi tion by itself (Bachelard et aI., 1993) . Furthermore, the release of excitatory amino acid neurotransmitters during exposure to hypoglycemia combined with hypoxial ischemia accentuates calcium influx into cells (Olney, 1994) . As excessive calcium influx into brain cells is recognized as a critical step in the initiation of cell death (Choi, 1988; Siesjo, 1991; Siesjo and Bengtsson, 1989) , this finding may help explain how exposure to hypogly cemic respiratory depression can enhance brain injury.
The prominent microglial activation we observed in the brains of all cats exposed to hypoglycemic respiratory depression supports an excitatory amino acid type of injury because microglial activation suggests specific in jury to neuronal processes (Moffett and Paden, 1994) and resembles the axon-sparing dendritic lesions observed after energy depletion-induced hypoglycemic injury in rats (Auer and Siesjo, 1993) . The present HG/RD model in cats enhances the com parability with important aspects of human hypoglyce mia. Thus, the markedly hypoglycemic cat regularly shows seizures, a clinically prominent symptom of se vere hypoglycemia in juvenile type 1 diabetes (Davis et aI., 1997) . Maybe due to the development of energy fail ure, hypoglycemic rats fail to show seizures. Also, pro longed fasting, as used in this model, is a common pre disposing factor leading to symptomatic hypoglycemia in insulin-treated diabetes and for drug-induced coma (Seltzer, 1989; Davis et aI., 1997) .
The HG and HG/RD models in the cat may provide a better understanding of hypoglycemia-related clinical findings. Thus, the lack of brain injury in cats exposed to marked hypoglycemia parallels the low (2%) incidence of brain damage in patients with drug-induced hypogly cemic coma even though the neuroglycopenia is suffi cient to impair brain function in both (Seltzer, 1989) . The result that hypoglycemia, even of moderate severity, acts synergistically with respiratory depression to produce a high yield of brain injury may relate to the clinical ob servation that hypoglycemic coma can be associated with breathing abnormalities, seizures, and ultimately respira tory arrest, especially in young children (Lamminpaa and Vilska, 1990; Johnston et aI., 1997) . Thus, in a subset of patients experiencing hypoglycemic coma, the setting for combined exposure to hypoglycemic respiratory depres sion may be realized, leading to brain damage. Given the life-threatening nature of hypoglycemia and of respira tory impairments, death, though, may be more common than survival with brain injury. Importantly, infants sus tain brain damage from exposures to moderately reduced glycemia levels (Lucas et aI., 1988) , levels insufficient to damage the brain in other hypoglycemia models (Myers and Kahn, 1971; Auer et aI., 1984) . Lucas et aI. (1988) found that newborns with birth weights of <1,850 g ex hibited a 3.5-fold higher incidence of retarded mental development if they experienced 2':5 days of moderate reductions in plasma glucose concentrations «2.6 mmol). Frequent hypoglycemic episodes were more in jurious than more marked but less frequent episodes, Similarly, children with early-onset diabetes prone to de velop frequent hypoglycemic episodes also experience increased rates of intellectual deficits (Rovet et aI., 1987; Bergada et aI., 1989) . Because this age group is also prone to develop respiratory distress, a more frequent coexistence of respiratory problems and hypoglycemia leading to hypoglycemic respiratory depression equivalent exposures may underlie their increased preva lence of impaired brain development.
In this study, treating hypoglycemia associated with respiratory depression to hyperglycemia led to more se vere damage to the brain than its treatment to euglyce mia. The mechanisms accounting for this effect remain unclear. We have ruled out lactic acid accumulation to damaging levels during treatment by brain 1 H MR spec troscopy (de Courten-Myers et aI., 1997). Mannitol, added to the infusate to equilibrate the osmolality of the treating low-and high-glucose solutions, might have re duced the brain injury in the animals treated to euglyce mia by osmotically reducing the brain edema produced. However, because the infusion lasted only 10 minutes, this effect would have been short-lived and not likely to explain alone the large outcome difference observed be tween the two groups. A stronger influence may be ex pected from the hyperglycemia-induced increase in brain glucose concentrations that normalizes more slowly than the serum glucose concentrations (Wass and Lanier, 1996) . The associated osmotic gradient tends to aggra vate any brain edema present and thereby enhance the brain damage induced by the hypoglycemic respiratory depression. Whatever the mechanism, the observed ad verse effect of treating marked hypoglycemia compli cated by respiratory depression to hyper-rather than eu glycemia suggests that the evolving brain damage can be influenced by the mode of treating hypoglycemia. As the treatment phase is under clinical control, avoiding treat ment-induced hyperglycemic overshoots may minimize hypoglycemic brain injury. The goal of maintaining a normal serum glucose concentration during treatment al ready accords with the recommendation for treating isch emic brain injury (Wass and Lanier, 1996) .
